China biotech player Reistone raises $100m
Reistone, a novel drug developer incubated by Jiangsu Hengrui Pharmaceuticals, has raised a Series A of nearly USD 100m led by Huagai Capital.
Other investors include Yunion Healthcare Fund, Shanghai Zhangjiang Haoheng Innovative Equity Investment, Zero2IPO Industry Investment, and Hanne Capital. This is Reistone’s first external funding...
More on Greater China
Latest News
Mitsui, Nomura acquire real assets manager New Forests
Japan’s Mitsui & Co. and Nomura Holdings have agreed to acquire 100% of New Forests, an Australia-headquartered sustainable real assets investment manager focused on forestry, land management, and conservation.
Thai food supply chain player secures $23.5m Series B
Openspace Ventures has participated in a USD 23.5m Series B funding round for Freshket, a Thailand-based farm-to-table agricultural supply chain start-up.
Philippines fintech player Coins raises $30m
Coins, a Philippines-based financial technology provider focused on blockchain-enabled payment services, has received a USD 30m investment led by Ribbit Captial.
Coatue, Insight lead Series D for Indonesia's Xendit
Coatue Management and Insight Partners have led a USD 300m Series D round for Indonesian payments infrastructure platform Xendit.